tiprankstipranks
Trending News
More News >
Compass Therapeutics (CMPX)
NASDAQ:CMPX
US Market

Compass Therapeutics (CMPX) Income Statement

Compare
480 Followers

Compass Therapeutics Income Statement

Last quarter (Q4 2025), Compass Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Compass Therapeutics's net income was $-15.72M. See Compass Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 850.00K$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 850.00K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 72.84M$ 57.48M$ 50.36M$ 41.66M$ 81.88M
Depreciation and Amortization
$ 0.00$ 1.75M$ 1.89M$ 1.90M$ 1.62M
EBITDA
$ -72.84M$ -54.87M$ -48.47M$ -39.75M$ -80.19M
Operating Income
$ -72.84M$ -56.63M$ -50.36M$ -41.66M$ -81.88M
Other Income/Expenses
$ 6.35M$ 7.25M$ 7.87M$ 2.43M$ -299.00K
Pretax Income
$ -66.49M$ -49.38M$ -42.49M$ -39.23M$ -82.18M
Net Income
$ -66.49M$ -49.38M$ -42.49M$ -39.23M$ -82.18M
Per Share Metrics
Basic EPS
$ -0.42$ -0.36$ -0.33$ -0.35$ -1.31
Diluted EPS
$ -0.42$ -0.36$ -0.33$ -0.35$ -1.31
Weighted Average Shares Outstanding
157.69M 137.11M 127.03M 105.19M 62.87M
Weighted Average Shares Outstanding (Diluted)
157.69M 137.11M 127.03M 105.19M 62.87M
Currency in USD

Compass Therapeutics Earnings and Revenue History